HPV 6, 11 → genital warts

HPV 16, 18 → cervical cancer

HPV 31, 33, 45, 52, 58 → additional high-risk HPV types associated with cancer

Ages 9–14: 2 doses (0, 6 months) / Ages 15 and older: 3 doses (0, 2, 6 months)

Healthcare workers, International travelers, College students living in group settings, People at risk of exposure in outbreak areas.

Everyone aged 6 months and older

Malaria Prophylaxis

• Chloroquine-sensitive areas: Chloroquine, once weekly (start 1 week before travel – continue 4 weeks after return)

• Chloroquine-resistant areas: Mefloquine, once weekly (start 2 weeks before travel – continue 4 weeks after return)

• Mefloquine-resistant areas: Atovaquone-Proguanil, daily (start 1–2 weeks before travel – continue 1 week after return)

• All 11- to 12-year-old adolescents should receive a MenACWY vaccine. Since protection wanes, CDC recommends a MenACWY booster dose at age 16 years

• Adolescents or young adults

• Administer 2 doses, 6 months apart

Vaccine Type: Ty21a live attenuated oral vaccine (Vivotif capsules)

Administration: For individuals aged 5 years and older, taken every other day, total 3 doses (Day 1, Day 3, and Day 5).

Vaccine Type: IMOJEV(live, attenuated)

Administration: For adult, One dose.